Efficacy and tolerability of pregabalin in essential tremor: A randomized, double-blind, placebo-controlled, crossover trial

Journal of the Neurological Sciences

Volumn 285, Issue 1-2, 2009, Pages 195-197

  Ferrara, Joseph M ^a   Kenney, Christopher ^a   Davidson, Anthony L ^a   Shinawi, Lina ^a   Kissel, Abigail M ^a   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Essential tremor; Fahn Tolosa Marin Tremor Rating Scale (TRS); Pregabalin; Quality of Life in Essential Tremor Questionnaire (QUEST)

Indexed keywords

PLACEBO; PREGABALIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ESSENTIAL TREMOR; FEMALE; HUMAN; MALE; MEASUREMENT; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ANALYSIS OF VARIANCE; ANTICONVULSANTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESSENTIAL TREMOR; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 69749117734     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.06.044     Document Type: Article

References (12)

1. Zesiewicz T.A., Elble R., Louis E.D., Hauser R.A., Sullivan K.L., Dewey J.R., et al. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 64 (2005) 2008-2020
2. Louis E.D. Clinical practice. Essential tremor. N Engl J Med 345 (2001) 887-891
3. Montgomery S., Chatamra K., Pauer L., Whalen E., and Baldinetti F. Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder. Br J Psychiatry 193 (2008) 389-394
4. Zesiewicz T.A., Ward C.L., Hauser R.A., Salemi J.L., Siraj S., Wilson M.C., et al. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor. Mov Disord 22 (2007) 1660-1663
5. Findley L.J., and Koller W.C. Definitions and behavioural classification. In: Findley L.J., and Koller W.C. (Eds). Handbook of tremor disorders (1995), Marcel Dekker, New York 1-5
6. Fahn S., Tolosa E., and Marin C. Clinical rating scale for tremor. In: Jankovic J., and Tolosa E. (Eds). Parkinson's disease and movement disorders (1988), Urban and Schwarzenberg, Baltimore 225-234
7. Tröster A.I., Pahwa R., Fields J.A., Tanner C.M., and Lyons K.E. Quality of Life in Essential Tremor Questionnaire (QUEST): development and initial validation. Parkinsonism Relat Disord 11 (2005) 367-373
8. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 32 (1959) 50-55
9. Leger D., Scheuermaier K., Raffray T., Metlaine A., Choudat D., and Guilleminault C. HD-16: a new quality of life instrument specifically designed for insomnia. Sleep Med 6 (2005) 191-198
10. Ondo W.G., Jankovic J., Connor G.S., Pahwa R., Elble R., Stacy M.A., et al., Topiramate Essential Tremor Study Investigators. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology 66 (2006) 672-677
11. Stacy M.A., Elble R.J., Ondo W.G., Wu S.C., Hulihan J., and TRS study group. Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor. Mov Disord 22 (2007) 833-838
12. Lyrica [package insert]. New York, NY: Pfizer Inc.; Revised 6/2007.